References
- Brambilla E., Travis W. D. Adenosquamous carcinoma. In: Travis W. D., Brambilla E., Muller-Hermelink H. K., Harris C. C. (eds.). WHO classification. Pathology&Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press, 2004: 51–52.
- Jeanmart M., Lantuejoul S., Fievet F., Moro D., Sturm C., Brambilla C. et al. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clinical Cancer Research, 2003, 9: 2195–2203.
- Ullmann R., Bongiovanni M., Halbwedl I., Petzmann S., Gogg- Kammerer M., Sapino A. et al. Bronchiolar columnar cell dyspla-sia-genetic analysis of a novel preneoplastic lesion of peripheral lung. Virchows Arch, 2003, 442: 429–436.
- Wang G. F., Lai M. D., Yang R. R., Chen P H., Su Y. Y., Lv B. J. et al. Histological types and significance of bronchial epithelial dysplasia. Modern Pathology, 2006, 19: 429–437.
- Kanazawa H., Ebina M., Ino-oka C., Shimizukawa M., TakahashiT. et al. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung. Am J Pathol, 2000, 156: 1289–1298.
- Bastide K., Ugolin C., Levalois C., Bernaudin J. F., Chevillard S. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level ? Lung Cancer, 2010, 68: 1–9.
- Kang S. M., Kang H. J., Shin J. H., Kim H., Shin D. H. et al. Identical Epidermal Growth Factor Receptor mutations in adeno-carcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung. Cancer, 2007, 109: 581587.
- Lantuejoul S., Salameire D., Salon C., Brambilla E. Pulmonary preneoplasia-sequential molecular carcinogenetic events. Histopathology, 2009, 54: 43–54.
- Kalomenidis I., Orphanidou D., Papamicalis G., Vassilakopoulos T., Skorilas A., Rasidakis A. et al. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalign lesions: Association with clinical characteristics. Lung, 2002, 179: 265–278.
- Kerr K. M. Pulmonary preinvasive neoplasia. J Clin Pathol, 2001, 54: 257–271.
- Pankiewicz W., Minarowski L., Niklinska W., Naumnik W., Nikilinski J., Chyczewski L. Immunohistochemical markers of carcinogenesis in the lung. Folia Histochemica et cytobiologica, 2007, 45: 65–74.
- Massion P. P., zou Y., Uner H., Kiatsimkul P., Wolf H. J., Baron A. E. et al. Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung carcer. Plos One, 2009, 4: 1–7.
- Jarrard J. A., Lionnoila I., Lee H. R., Steinberg S. M., WitschiH., Szabo E. Mud is anovel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Research, 1998, 58: 5582–5589.